Table 3. ROC analysis to predict the diagnostic impact of the miRNA and mRNA target expression.
Marker | AUC (95% CI) | |
---|---|---|
between N and ccRCC | between ccRCC-M0 and ccRCC-M1 | |
HS6ST2 | 0.974 (0.941–1.000)**** | 0.697 (0.492–0.902)ns |
LOX | 0.849 (0.725–0.973)**** | 0.811 (0.644–0.979)** |
miR-141 | 0.912 (0.815–1.000)**** | 0.539 (0.315–0.763)ns |
miR-145 | 0.711 (0.565–0.857)** | 0.694 (0.492–0.897)ns |
AUC = area under the curve; N = non-malignant renal tissue from ccRCC patients; ccRCC = malignant renal tissue from ccRCC patients; ccRCC-M0 = malignant renal tissue from ccRCC patients without metastasis; ccRCC-M1 = malignant renal tissue from ccRCC patients with metastasis
** p < 0.01
**** p < 0.0001; ns = not significant